Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.39895 | 54 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.38109 | 55 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.38424 | 55 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.17432 | 51 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.33405 | 55 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.86081 | 63 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.41731 | 54 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.35952 | 55 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.42285 | 57 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.37226 | 55 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.21971 | 51 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.32051 | 55 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.37335 | 55 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.37339 | 55 |